| Submit your comments on this article |
| Science & Technology |
| HCQ Helps Contain COVID-19 Cases: New Evidence and a Major Retraction |
| 2020-07-13 |
| [PJMedia] Hydroxychloroquine (HCQ) — the controversial COVID-19 treatment touted by President Donald Trump — might be gaining new traction in the fight against the Wuhan coronavirus. The latest positive results come from Vadodara, India, where city officials have conducted a major study involving more than 300,000 people, including “health workers and other frontline staff.” The Indian Express reports: The administration has analysed a sample of over 1 lakh [lakh = 100,000] residents, who were mostly close contacts of positive persons and the effect of HCQ in containing the transmission of the virus. According to the analysis, of the 48,873 close contacts of positive patients who took one dose of HCQ, 102 turned Covid-19 positive and 12 succumbed to the infection whereas 48 of the 17,776 close contacts of positive patients who took two doses of HCQ turned positive and only one died. The study also states that of the 33,563 close contacts of patients who took three HCQ doses, 43 tested positive and one died. Local health official Dr. Devesh Patel told the paper, “It has shown positive results. We have the numbers and not one person has complained of complications. The only side effect reported is mild gastritis, which is common with administering heavy medicines and can be effectively handled.” In other words, anyone who has taken the much more common azithromycin antibiotic for a simple sinus infection has probably suffered about the same distress — all gastric — as a subject of the Vadodara study. Dr. Mohammad Hussain, who runs Vadodara’s Faith Hospital, told the Express, “There are conflicting studies about the use of HCQ. While initially the US studies rejected it and cited side-effects, European countries backed its prophylactic use. In Vadodara, it has shown positive results. We have been able to restrict cases in clusters. Nagarwada no longer has a huge number of cases.” Hussain reiterated that no serious side effects were reported. |
| Posted by:g(r)omgoru |
| #4 India doesnt have the choice of paying for Big Pharma solutions. They have to "go with what they got", and this seems to work a lot better than unobtainable solutions. |
| Posted by: Marilyn Tojo7566 2020-07-13 23:04 |
| #3 The direct quote (beginning 'The administration....) includes results for about 100k people. The narrative before that says the study involved 300k people. The Indian Express article said some people were taking two pills the first day and one after that each day which muddles the quoted section. No links to a published paper. |
| Posted by: lord garth 2020-07-13 17:06 |
| #2 Control comes from quantities - you've 3 points: enough to draw a curve. |
| Posted by: g(r)omgoru 2020-07-13 16:22 |
| #1 No control group where no patients took HCQ WTF? |
| Posted by: lord garth 2020-07-13 16:14 |